| mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
| mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
0.003 |
0.9 |
| mRNA |
BIRB 0796 |
FIMM |
pan-cancer |
AAC |
-0.015 |
0.9 |
| mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.9 |
| mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
| mRNA |
PD-0332991 |
FIMM |
pan-cancer |
AAC |
-0.013 |
0.9 |
| mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |